Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 70 Records) |
| Query Trace: Fibrosis and TM6SF2[original query] |
|---|
| Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program. PloS one 2020 15 (8): e0237430. Serper Marina, Vujkovic Marijana, Kaplan David E, Carr Rotonya M, Lee Kyung Min, Shao Qing, Miller Donald R, Reaven Peter D, Phillips Lawrence S, O'Donnell Christopher J, Meigs James B, Wilson Peter W F, Vickers-Smith Rachel, Kranzler Henry R, Justice Amy C, Gaziano John M, Muralidhar Sumitra, Pyarajan Saiju, DuVall Scott L, Assimes Themistocles L, Lee Jennifer S, Tsao Philip S, Rader Daniel J, Damrauer Scott M, Lynch Julie A, Saleheen Danish, Voight Benjamin F, Chang Kyong-Mi, |
| Insights into genetic variants associated with NASH-fibrosis from metabolite profiling. Human molecular genetics 2020 Jul . Mann Jake P, Pietzner Maik, Wittemans Laura B, Rolfe Emmanuela De Lucia, Kerrison Nicola D, Imamura Fumiaki, Forouhi Nita G, Fauman Eric, Allison Michael E, Griffin Jules L, Koulman Albert, Wareham Nicholas J, Langenberg Claud |
| Metabolic and Genetic Risk Factors Are the Strongest Predictors of Severity of Alcohol-Related Liver Fibrosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2020 Dec . Israelsen Mads, Juel Helene Bæk, Detlefsen Sönke, Madsen Bjørn Stæhr, Rasmussen Ditlev Nytoft, Larsen Trine R, Kjærgaard Maria, Fernandes Jensen Mary Jo, Stender Stefan, Hansen Torben, Krag Aleksander, Thiele Maja, |
| Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores. Journal of hepatology 2020 11 74 (4): 775-782. Bianco Cristiana, Jamialahmadi Oveis, Pelusi Serena, Baselli Guido, Dongiovanni Paola, Zanoni Irene, Santoro Luigi, Maier Silvia, Liguori Antonio, Meroni Marica, Borroni Vittorio, D'Ambrosio Roberta, Spagnuolo Rocco, Alisi Anna, Federico Alessandro, Bugianesi Elisabetta, Petta Salvatore, Miele Luca, Vespasiani-Gentilucci Umberto, Anstee Quentin M, Stickel Felix, Hampe Jochen, Fischer Janett, Berg Thomas, Fracanzani Anna Ludovica, Soardo Giorgio, Reeves Helen, Prati Daniele, Romeo Stefano, Valenti Lu |
| PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease. World journal of hepatology 2020 Oct 12 (10): 792-806. Lisboa Quelson Coelho, Nardelli Mateus Jorge, Pereira Patrícia de Araújo, Miranda Débora Marques, Ribeiro Stephanie Nunes, Costa Raissa Soares Neves, Versiani Camila Azevedo, Vidigal Paula Vieira Teixeira, Ferrari Teresa Cristina de Abreu, Couto Claudia Alv |
| Effects of PNPLA3, TM6SF2 and SAMM50 on the development and severity of non-alcoholic fatty liver disease in children. Pediatric obesity 2021 Sep e12852. Lee Kyung Jae, Moon Jin Soo, Kim Nan Young, Ko Jae Su |
| Epidemiology and risk-stratification of NAFLD-associated HCC. Journal of hepatology 2021 8 75 (6): 1476-1484. Ioannou George |
| A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021 6 20 (3): 658-673. De Vincentis Antonio, Tavaglione Federica, Jamialahmadi Oveis, Picardi Antonio, Antonelli Incalzi Raffaele, Valenti Luca, Romeo Stefano, Vespasiani-Gentilucci Umber |
| Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease. Hepatology international 2021 Jun . Paternostro Rafael, Staufer Katharina, Traussnigg Stefan, Stättermayer Albert-Friedrich, Halilbasic Emina, Keritam Omar, Meyer Elias L, Stift Judith, Wrba Fritz, Sipos Bence, Canbay Ali, Schlattjan Martin, Aigner Elmar, Datz Christian, Stickel Felix, Schafmayer Clemens, Hampe Jochen, Buch Stephan, Prager Gerhard, Munda Petra, Mandorfer Mattias, Ferenci Peter, Trauner Micha |
| The impact of genetic risk on liver fibrosis in non-alcoholic fatty liver disease as assessed by magnetic resonance elastography. Alimentary pharmacology & therapeutics 2021 May . Ajmera Veeral, Liu Amy, Bettencourt Ricki, Dhar Debanjan, Richards Lisa, Loomba Roh |
| A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC? Cancers 2021 4 13 (6): . Eldafashi Nardeen, Darlay Rebecca, Shukla Ruchi, McCain Misti Vanette, Watson Robyn, Liu Yang Lin, McStraw Nikki, Fathy Moustafa, Fawzy Michael Atef, Zaki Marco Y W, Daly Ann K, Maurício João P, Burt Alastair D, Haugk Beate, Cordell Heather J, Bianco Cristiana, Dufour Jean-François, Valenti Luca, Anstee Quentin M, Reeves Helen |
| The role of PNPLA3 and TM6SF2 polymorphisms on liver fibrosis and metabolic abnormalities in Brazilian patients with chronic hepatitis C. BMC gastroenterology 2021 2 21 (1): 81. Oliveira Arthur Ivan N, Malta Fernanda M, Zitelli Patricia Momoyo Y, Salles Ana Paula M, Gomes-Gouvea Michele S, Nastri Ana Catharina S, Pinho Joao Renato R, Carrilho Flair J, Oliveira Claudia P, Mendes-Corrêa Maria Cássia, Pessoa Mario G, Mazo Daniel |
Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study.
The Lancet. Oncology 2021 12 23 (1): 161-171. Trépo Eric, Caruso Stefano, Yang Jie, Imbeaud Sandrine, Couchy Gabrielle, Bayard Quentin, Letouzé Eric, Ganne-Carrié Nathalie, Moreno Christophe, Oussalah Abderrahim, Féray Cyrille, Blanc Jean Frédéric, Clément Bruno, Hillon Patrick, Boursier Jérôme, Paradis Valérie, Calderaro Julien, Gnemmi Viviane, Nault Jean-Charles, Guéant Jean-Louis, Devière Jacques, Archambeaud Isabelle, Vitellius Carole, Turlin Bruno, Bronowicki Jean-Pierre, Gustot Thierry, Sutton Angela, , Ziol Marianne, Nahon Pierre, Zucman-Rossi Jessi |
| Genetic Polymorphisms and Clinical Features in Diabetic Patients With Fatty Liver: Results From a Single-Center Experience in Southern Italy. Frontiers in medicine 2021 8 737759. Villani Rosanna, Magnati Grazia Pia, De Girolamo Giuseppe, Sangineto Moris, Romano Antonino Davide, Cassano Tommaso, Serviddio Gaeta |
| Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Hepatology communications 2021 10 6 (3): 535-549. Meroni Marica, Longo Miriam, Lombardi Rosa, Paolini Erika, Macchi Chiara, Corsini Alberto, Sirtori Cesare R, Fracanzani Anna Ludovica, Ruscica Massimiliano, Dongiovanni Pao |
| Study of CXCL9-11 gene polymorphisms in liver fibrosis among patients with chronic hepatitis C. Pathogens and disease 2021 1 79 (3): . Magri Mariana Cavalheiro, Alvarez Maria Stella Montanha, Iogi Anny Ayumi, Alves Grayce Mendes, Manchiero Caroline, Dantas Bianca Peixoto, Prata Thamiris Vaz Gago, Nunes Arielle Karen da Silva, Tengan Fátima Miti |
| Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease. iScience 2022 9 25 (9): 104949. Sen Partho, Govaere Olivier, Sinioja Tim, McGlinchey Aidan, Geng Dawei, Ratziu Vlad, Bugianesi Elisabetta, Schattenberg Jörn M, Vidal-Puig Antonio, Allison Michael, Cockell Simon, Daly Ann K, Hyötyläinen Tuulia, Anstee Quentin M, Oreši? Mat |
| Effect of common genetic variants on the risk of cirrhosis in non-alcoholic fatty liver disease during 20?years of follow-up. Liver international : official journal of the International Association for the Study of the Liver 2022 9 42 (12): 2769-2780. Holmer Magnus, Ekstedt Mattias, Nasr Patrik, Zenlander Robin, Wester Axel, Tavaglione Federica, Romeo Stefano, Kechagias Stergios, Stål Per, Hagström Hann |
| Genetic variants associated with steatohepatitis and liver fibrosis in HIV-infected patients with NAFLD. Frontiers in pharmacology 2022 13 905126. Busca C, Arias P, Sánchez-Conde M, Rico M, Montejano R, Martín-Carbonero L, Valencia E, Moreno V, Bernardino J I, Olveira A, Abadía M, González-García J, Montes M |
| PNPLA3 and TM6SF2 genetic variants and hepatic fibrosis and cirrhosis in Pakistani chronic hepatitis C patients: a genetic association study. BMC gastroenterology 2022 Aug 22 (1): 401. Rauff Bisma, Alzahrani Badr, Chudhary Shafiq A, Nasir Bilal, Mahmood Saqib, Bhinder Munir Ahmad, Faheem Muhammad, Amar A |
| Improvement of liver fibrosis, but not steatosis, after HCV eradication as assessment by MR-based imaging: Role of metabolic derangement and host genetic variants. PloS one 2022 17 (6): e0269641. Chuaypen Natthaya, Siripongsakun Surachate, Hiranrat Pantajaree, Tanpowpong Natthaporn, Avihingsanon Anchalee, Tangkijvanich Pis |
| Influence of Type 2 Diabetes in the Association of PNPLA3 rs738409 and TM6SF2 rs58542926 Polymorphisms in NASH Advanced Liver Fibrosis. Biomedicines 2022 Apr 10 (5): . Gabriel-Medina Pablo, Ferrer-Costa Roser, Rodriguez-Frias Francisco, Ciudin Andreea, Augustin Salvador, Rivera-Esteban Jesus, Pericàs Juan M, Selva David Martin |
| Nonalcoholic fatty liver disease risk and histologic severity are associated with genetic polymorphisms in children. Hepatology (Baltimore, Md.) 2022 5 77 (1): 197-212. Goyal Nidhi P, Rosenthal Sara B, Nasamran Chanod, Behling Cynthia A, Angeles Jorge E, Fishbein Mark H, Harlow Kathryn E, Jain Ajay K, Molleston Jean P, Newton Kimberly P, Ugalde-Nicalo Patricia, Xanthankos Stavra A, Yates Katherine, Schork Nicholas J, Fisch Kathleen M, Schwimmer Jeffrey B, |
| Evaluation of the association of a variant in PNPLA3 and TM6SF2 with fibrosis progression in patients with chronic hepatitis C infection after eradication: A retrospective study. Gene 2022 Feb 820 146235. Kang Qian, Xu Jinghang, Luo Hao, Tan Ning, Chen Hongyu, Cheng Ran, Pan Jiali, Han Yifan, Yang Yuqing, Liu Dan, Xi Hongli, Yu Min, Xu Xiaoyu |
| MTARC1 and HSD17B13 Variants Have Protective Effects on Non-Alcoholic Fatty Liver Disease in Patients Undergoing Bariatric Surgery. International journal of molecular sciences 2022 12 23 (24): . Kalinowski Piotr, Smyk Wiktor, Nowosad Ma?gorzata, Paluszkiewicz Rafa?, Micha?owski ?ukasz, Ziarkiewicz-Wróblewska Bogna, Weber Susanne N, Milkiewicz Piotr, Lammert Frank, Zieniewicz Krzysztof, Krawczyk Marc |
| Different effects of low muscle mass on the risk of non-alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort. Journal of cachexia, sarcopenia and muscle 2022 11 14 (1): 260-269. Choe Hun Jee, Lee Hyunsuk, Lee DongHo, Kwak Soo-Heon, Koo Bo Kyu |
| TM6SF2 rs58542926 is related to hepatic steatosis, fibrosis and serum lipids both in adults and children: A meta-analysis. Frontiers in endocrinology 2022 11 13 1026901. Li Xue-Ying, Liu Zheng, Li Li, Wang Hai-Jun, Wang H |
| Influence of the Bile Acid Transporter Genes ABCB4, ABCB8, and ABCB11 and the Farnesoid X Receptor on the Response to Ursodeoxycholic Acid in Patients with Nonalcoholic Steatohepatitis. Journal of personalized medicine 2023 7 13 (7): . Henriette Kreimeyer, Katharina Vogt, Tobias Götze, Jan Best, Oliver Götze, Jochen Weigt, Alisan Kahraman, Mustafa Özçürümez, Julia Kälsch, Wing-Kin Syn, Svenja Sydor, Ali Canbay, Paul Man |
| Characteristics and long-term mortality of patients with non-MAFLD hepatic steatosis. Hepatology international 2023 3 . Fan Hong, Liu Zhenqiu, Zhang Pengyan, Wu Sheng, Han Xinyu, Huang Yiwen, Zhu Yichen, Chen Xingdong, Zhang Tiej |
| Genetic Variants Determine Treatment Response in Autoimmune Hepatitis. Journal of personalized medicine 2023 3 13 (3): . Zandanell Stephan, Balcar Lorenz, Semmler Georg, Schirmer Alex, Leitner Isabella, Rosenstatter Lea, Niederseer David, Sotlar Karl, Schneider Anna-Maria, Strasser Michael, Gensluckner Sophie, Feldman Alexandra, Datz Christian, Aigner Elm |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: